Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stewart Factor DO

Stewart Factor DO

Professor and Director, Jean and Paul Amos Parkinson Disease and Movement Disorder Program, Emory University School of Medicine, Atlanta, Georgia

Dr. Factor is Professor, Director of Movement Disorders and Vance Lanier Chair of Neurology at Emory University School of Medicine. He received his DO Degree in 1982, completed Neurology Residency at Albany Medical Center in 1986 and Fellowship at University of Miami in 1988.

Memberships include AAN, ANA, MDS (1987), PSG (1994), HSG (1996), and the DSG (1996). He is past Chair of the Movement Disorders Section of the AAN. He was member of the following committees, AAN Movement Disorder Section Executive Committee, MDS education committee and Archive committee (Chair), PSG executive committee, nominating committee and budget committee HSG executive committee and nominating committee, DSG executive committee. He has >300 peer reviewed publications.

Research areas of interest include PD biomarkers, freezing of gait in PD, clinical trials, genetics in PD, and tardive syndrome. As fellowship program director in movement disorders and has mentored >20 fellows in the last 15 years.


Dr. Factor reports the following:

  • Honoraria: Lundbeck, Biogen, Takeda.
  • Grants: Medtronics, Boston Scientific, Sun Pharmaceuticals Advanced Research Company, Aspen, Biohaven, Impax Therapeutics, Neurocrine, Voyager, Addex Pharma S.A., Prilenia Therapeutics, CHDI Foundation, Michael J. Fox Foundation, NIH 1 P50 NS123103-01, NIH 1R01NS125294-01, Parkinson Foundation
  • Royalties: Demos, Blackwell Futura, Springer for textbooks, Uptodate
  • Other: Signant Health (Bracket Global LLC)